Study: Watch Southeast Asia Flu Origins For Vaccine Development
This article was originally published in PharmAsia News
A newly published study traced the deadliest influenza viruses to Asia, which tends to develop epidemics that feed on each other to spread. The researchers reported in the journal Science suggests drug makers may be able to develop vaccines that match the latest strains of the flu. Researchers said weather patterns and travel among East and Southeast Asian nations lead to overlapping flu epidemics, eventually reaching other continents six to nine months later. Better surveillance of flu strains circulating in Asia could lead to more specific vaccines, the report suggests. (Click here for more
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.